In our studies, elevated plasma/serum ApoC-III concentration was one of the most characteristic features in pathologically changed samples and supports previous observations suggesting its critical role in promoting atherosclerosis and other metabolic diseases [45, 46]. This evidence concerns the gene APOC3 and metabolic disease.